This study investigated the severity of hirsutism and its correlation with serum total testosterone (tT) levels in 87 patients with polycystic ovary syndrome (PCOS) and 85 healthy control subjects from the south-eastern region of Turkey. A wide range of variability exists in both hirsutism and modified Ferriman-Gallwey (mFG) scores. Similar mFG scores and serum tT levels were found compared with previous studies of general populations, but lower scores than those previously reported from Turkey. The incidence of hirsutism was lower in hyperandrogenic PCOS patients compared with nonhyperandrogenic PCOS patients. There was no correlation between serum tT levels and the rate of hirsutism in patients with PCOS. Heritability, testosterone receptor sensitivity, 5a reductase activity or environmental/socioeconomic factors may play a role in the development of clinical hirsutism. Larger scale studies are needed to clarify which other factors may be responsible and to confirm these results.
Introduction
Polycystic ovary syndrome (PCOS), a genetically complex endocrine disorder of uncertain aetiology, is a common cause of anovulatory infertility, menstrual dysfunction and hirsutism. 1 Both the presence and severity of hyperandrogenism, menstrual irregularities and infertility are heterogeneous in PCOS. 2 There is no distinct biochemical abnormality or unique phenotype that allows PCOS-related hyperandrogenism to be distinguished from other forms and there is difficulty in introducing generally accepted diagnostic criteria for PCOS. 1,2 Currently, the diagnosis of PCOS is based on the following criteria In 1961 Ferriman and Gallwey 4 described a scoring system to determine the degree of hirsutism. The density of terminal hairs at 11 different body sites was scored: upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, arm, forearm, thigh and lower leg. For each of these areas, a score from 0 (absence of terminal hairs) to 4 (extensive terminal hair growth) was assigned. Hair growth over the forearm and lower leg was noted to be less sensitive and modifications of the Ferriman-Gallwey method have excluded scoring of these areas. 4 Subsequent studies have shown that three body areas, the buttocks/perineum, sideburns and the neck/lower jaw, contributed more substantially to the total hirsutism score than the nine body areas in the modified Ferriman-Gallwey (mFG) scoring system; however, the mFG system remains the most widely used method for visually scoring excess terminal body or facial hair growth in the assessment of hirsutism. 1,5 -7 Androgen levels and hirsutism scores have been evaluated in many previous studies, but a relationship between clinical hirsutism and the severity of hyperandrogenism has not been demonstrated. 8 -12 Coskun et al. 13 reported increased androgen levels and hirsutism scores in patients and control subjects from the Mediterranean region of Turkey, suggesting that subjects from this region have a greater body hair density. Their study failed, however, to determine whether there was a correlation between androgen levels and hirsutism score.
The present study was designed to investigate the severity of hirsutism in patients with PCOS and its correlation with serum total testosterone (tT) levels in patients from the south-eastern region of Turkey. 
Patients and methods

STUDY POPULATION
DIAGNOSTIC CRITERIA
Patients were diagnosed with PCOS according to the Rotterdam Criteria. 3 Oligoanovulation was defined as menstrual dysfunction (oligoamenorrhoea), characterized by six or fewer menstrual periods per year. Polycystic ovaries were determined by visualization (via transvaginal ultrasound) of ≥ 12 follicles of diameter 2 -9 mm on each ovary on days 2 -5 of menstruation. A serum tT level > 75 ng/dl indicated hyperandrogenism. The mFG scoring system was employed for the diagnosis of hirsutism, with a total score ≥ 8 accepted as clinical hirsutism. 5 The age, age at menarche and mFG scores of patients and controls were noted. Body mass index (BMI) was calculated as body weight (kg) / height (m 2 ). Serum and plasma samples were collected on the same day as transvaginal ultrasound was undertaken,
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between 08:00 h and 10:00 h after an overnight fast of at least 12 h during the early follicular phase of the menstrual cycle, or on random days in amenorrhoeic patients. Luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol, prolactin and tT concentrations were determined using an ADVIA Centaur ® XP immunoassay system (Siemens Healthcare Diagnostics, NY, USA) according to the manufacturer's instruction.
STATISTICAL ANALYSES
Results are presented as mean ± SD or number and percentage of patients. Statistical significance was evaluated using the Student's t-test and the χ 2 -test. Correlations between variables were evaluated using Pearson's correlation coefficient. All statistical analyses were performed using SPSS ® statistical package, version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A P-value ≤ 0.05 was considered to be statistically significant.
Results
The study recruited 87 PCOS patients and 85 healthy female controls. There was no significant difference between patients and controls in terms of age or age at menarche. The mean BMI and the percentage of overweight/obese individuals were significantly higher in patients than controls (P < 0.0001; Table 1 ). The mean BMI of patients with hyperandrogenism was significantly higher than hyperandrogenic control subjects (P = 0.031) and normal control subjects (P < 0.0001; Table 2 ). There was no significant correlation between serum tT levels and BMI or obesity.
There were no significant differences between patients and controls in terms of mean serum FSH and prolactin levels, but mean serum LH, estradiol and tT levels were significantly higher in patients with PCOS than in controls (P < 0.0001, P = 0.011 and P < 0.0001, respectively; Table 1 ).
The mean mFG score and the incidence of hirsutism (mFG score ≥ 8) were significantly Table 1 ). Mean mFG scores were significantly higher in hyperandrogenic PCOS patients than in hyperandrogenic control subjects (P = 0.04) and were also significantly higher in PCOS patients who were not hyperandrogenic compared with control subjects who were not hyperandrogenic (P < 0.0001; Table 2 ). The mean mFG score of PCOS patients with hyperandrogenism was similar to that of PCOS patients who were not hyperandrogenic and there was also no statistically significant difference in mean mFG score between hyperandrogenic and non-hyperandrogenic healthy controls.
The incidence of hirsutism (mFG score ≥ 8) in hyperandrogenic PCOS patients was significantly greater than in hyper androgenic healthy controls with hirsutism, but was significantly less than in nonhyperandrogenic PCOS patients (P < 0.0001 for both comparisons; Table 2 ). In contrast, the incidence of hirsutism in hyperandrogenic healthy controls was significantly greater than in non-hyperandrogenic healthy controls (P < 0.0001). Non-hyperandrogenic PCOS patients had a very much greater incidence of hirsutism than non-hyperandrogenic healthy controls (P < 0.0001; Table 2 ). There were no significant correlations between serum tT levels or mean mFG scores and the incidence of hirsutism in patients or controls.
Discussion
Polycystic ovary syndrome is the most common cause of androgen excess in women. 14 17 -19 The present study investigated the severity of hirsutism in patients with PCOS and its relationship with serum tT levels. A statistically significant difference in tT levels, BMI, serum LH and estradiol between PCOS patients and healthy controls was found in the present study. A difference in gonadotropin secretion associated with increased BMI, insulin resistance and serum tT levels may be responsible for oligoanovulation in PCOS patients. 20, 21 Although the numbers of overweight and obese individuals were significantly higher among PCOS patients in the present study, they were lower than the previously reported rates of 30% -42%. 1,2, 22 It is possible that the lower rate of obesity in the present study was due to the relatively low mean age of the present study group and differences in ethnicity.
A meta-analysis of 3464 patients with PCOS found elevated serum tT levels in 37% of patients, 23 compared with a previous study from Turkey where 62% of patients had elevated tT. 13 Similar to the meta-analysis but different from the Turkish study, 38% of PCOS patients had elevated serum tT in the present study. Difference in observed serum tT levels may be related to the ethnic heterogeneity of the population of the present study or to the socioeconomic status of the patients with hirsutism. The incidence of hirsutism may vary among women with PCOS and seems to depend both on the extent of body hair distribution and the sensitivity of individual women to the body hair pattern. 24 Several previous studies have evaluated androgen levels and hirsutism scores, but a correlation between clinical hirsutism and the severity of hyperandrogenism has not been clearly demonstrated. 8 -13 DeUgarte et al. 25 reported that the diagnosis of hirsutism depends largely on the patient's perception rather than on their total mFG score. The 8 -13,23,26 A Turkish study employing the mFG scoring system found an incidence of hirsutism of 87%, leading the authors to suggest that women in the Mediterranean region have a higher amount of body hair. 27 The present study showed that 68% of 87 PCOS patients had mFG scores of ≥ 8. This is lower than Coskun et al., 13 who studied a similar ethnic population with comparable geographical and social characteristics and may be related to the ethnic heterogeneity of the south-east Turkey region. Hirsutism occurred in 15% of control subjects, which is in contrast to previously reported rates of 4.6 -10% in the general population. 28 -30 The higher rate of hirsutism in the general population of the present study accords with previous studies demonstrating higher body hair density in the Mediterranean region and Turkey. 13, 24, 31 The present study investigated the relationship between serum tT levels and mFG scores of PCOS patients and healthy controls. The mean mFG score of hyperandrogenic PCOS patients was similar to that of non-hyperandrogenic patients. Similarly, there was no difference between mean mFG scores of hyperandrogenic controls and non-hyperandrogenic controls. No correlation was detected between tT levels and the incidence of hirsutism among the PCOS patients. Hyperandrogenic PCOS patients had a higher mean mFG score than hyperandrogenic control subjects. We postulate that testosterone receptor sensitivity, 5α reductase activity, or environmental/socioeconomic factors may play a role in the development of clinical hirsutism and related complaints.
In accordance with previous reports, 8 -11 the present study showed variability in both hirsutism and mFG scores. The mFG scores and serum tT levels were similar to those in previous reports on general PCOS patients, 8 -11 but lower than previous studies from Turkey. 13 No correlation was detected between serum tT levels and the incidence of hirsutism in patients with PCOS. Heritability, testosterone receptor sensitivity, 5α reductase activity or environmental/socioeconomical factors may play a role in the development of clinical hirsutism. Larger-scale studies are needed to clarify which other factors may responsible and to confirm these results.
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